A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement

SELLAS Life Sciences Group (SLS) has entered an agreement with IMPACT-AML, a pan-European clinical network, to run a new ...
Stocktwits on MSN

SLS stock breaches $5 level after over 3 years: Retail now eyes buyout for as much as $25B

SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid ...
Stocktwits on MSN

Why is SLS stock drawing significant investor attention today?

The company said that 72 out of the prespecified 80 deaths required to trigger the final analysis have now occurred as of Dec. 26, 2025. ・That extended survival timeline may delay the anticipated year ...
Yahoo Finance

Assessing SELLAS Life Sciences Group (SLS) Valuation After Positive Leukemia Data and Supportive FDA Designations

SELLAS Life Sciences Group (SLS) is back on traders’ radar after fresh data from its leukemia program, including strong response rates and supportive FDA designations, helped spark a sharp move in the ...
Benzinga.com

SELLAS Life Sciences Stock Is Surging Higher: What's Going On?

SELLAS Life Sciences Group Inc (NASDAQ: SLS) shares are trading higher on Monday after initially dropping in premarket trading, reversing course as investors seem to react to new trial‑related updates ...